Elon Musk, the founder of Neuralink, announced that the first human recipient of the brain chip implant is recovering well after receiving the procedure on 28th January 2024.
Elon Musk added that the initial results of the trial show promising detection of neuron spikes.
Neuron spikes are actually the activity by neurons that use electrical and chemical signals to send information around the brain and to the body.
Last year, the US Food and Drug Administration (FDA) granted clearance for Neuralink to start its first brain chip implant trial on humans.
The Prime study, conducted by Neuralink, aims to assess the safety and functionality of its wireless brain-computer interface.
Neuralink announced its implant trial in September, during which a specially developed robot will surgically implant the ultra-fine threads of the implant to facilitate signal transmission within participants' brains.
This interface has the potential to enable individuals with quadriplegia or paralysis of all four limbs to control devices using their thoughts.
So let’s hope for the success of this groundbreaking technology.
Elon Musk added that the initial results of the trial show promising detection of neuron spikes.
Neuron spikes are actually the activity by neurons that use electrical and chemical signals to send information around the brain and to the body.
Last year, the US Food and Drug Administration (FDA) granted clearance for Neuralink to start its first brain chip implant trial on humans.
The Prime study, conducted by Neuralink, aims to assess the safety and functionality of its wireless brain-computer interface.
Neuralink announced its implant trial in September, during which a specially developed robot will surgically implant the ultra-fine threads of the implant to facilitate signal transmission within participants' brains.
This interface has the potential to enable individuals with quadriplegia or paralysis of all four limbs to control devices using their thoughts.
So let’s hope for the success of this groundbreaking technology.
No comments:
Post a Comment